Sonova Holding AG
0QPY.L
London Stock Exchange203.60
CHF
+1.45
- -
Sonova Holding AG
0QPY.L
(London Stock Exchange)
Recent
price
203.60
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Sonova Holding AG, headquartered in Stäfa, Switzerland and founded in 1947, develops, manufactures and markets innovative hearing care solutions worldwide, including hearing aids, cochlear implants, personal audio devices, wireless communication systems and audiological care services; it operates through four main business segments--Hearing Instruments, Audiological Care, Consumer Hearing and Cochlear Implants--with core brands Phonak, Unitron, AudioNova, Sennheiser (under license) and Advanced Bionics, as well as regional brands. The company offers a broad portfolio of hearing instruments such as behind-the-ear (BTE), receiver-in-canal (RIC), custom in-the-ear (ITE) and invisible extended-wear models; cochlear implants and related systems; hearing protection products; FM systems; and consumer electronics like MOMENTUM 4 Wireless headphones. Sonova serves private clinics, retailers, wholesalers, governments and individual consumers across more than 100 countries in Europe, the Middle East, Africa, the Americas and Asia-Pacific through subsidiaries and independent distributors. In recent developments, Sonova launches the Phonak Infinio and Audéo Sphere Infinio platforms featuring AI-driven speech enhancement via the DEEPSONIC chip and ERA chip, alongside Infinio Ultra, Virto R Infinio rechargeable ITE devices and enhancements like AutoSense OS 7.0 and EasyGuard wax management; Unitron expands its Vivante platform with Stride V-M and V-SP models and introduces Ativo hearing aids, while Advanced Bionics debuts the AB ListenFit app and Advanced DigiCare tools for remote support and hearing tracking. The company pursues bolt-on acquisitions to expand its Audiological Care network, primarily in Australia, Canada, Germany, France and other markets, and implements structural optimizations including a new four-region organizational model for Hearing Instruments and Audiological Care starting November 2025 to boost customer centricity and regional agility in North America, EMEA & Latin America, Asia-Pacific (excluding China) and China. Sonova reports strong HY 2025/26 sales growth of 4.9% in local currencies to CHF 1,815.4 million, with sustained market share gains in Hearing Instruments and Audiological Care, normalized EBITA up 16.0% to CHF 316.1 million, and confirms FY 2025/26 outlook for 5-9% sales growth and 14-18% normalized EBITA growth at constant exchange rates.